Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Hunger

Showing results (201-210 of 346) with videos related to

Pageof 35
Sort By:
Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.
Blood|September 1, 2011
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Alex Kentsis, Takaomi Sanda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]Deepa Bhojwani, Huining Kang, Renee X Menezes, et al.
The New England Journal of Medicine|April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemiaMartin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.
NAR Cancer|December 15, 2022
A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1Adria Closa, Marina Reixachs-Solé, Antonio C Fuentes-Fayos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group studyKirk R Schultz, W Paul Bowman, Alexander Aledo, et al.
Blood|February 4, 2015
Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemiaShannon L Maude, Sibasish Dolai, Cristina Delgado-Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2019
Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology GroupJennifer L McNeer, Meenakshi Devidas, Yunfeng Dai, et al.
JCO Precision Oncology|May 26, 2021
NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical OutcomeXiaonan Zhao, Chelsea Kotch, Elizabeth Fox, et al.
British Journal of Haematology|December 25, 2025
Philadelphia chromosome-positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challengeAdriana Balduzzi, Maria Grazia Valsecchi, Thai Hoa Tran, et al.
Pageof 35

Showing results (201-210 of 346) with videos related to

Sort By:
Pageof 35
Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.
Blood|September 1, 2011
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Alex Kentsis, Takaomi Sanda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]Deepa Bhojwani, Huining Kang, Renee X Menezes, et al.
The New England Journal of Medicine|April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemiaMartin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.
NAR Cancer|December 15, 2022
A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1Adria Closa, Marina Reixachs-Solé, Antonio C Fuentes-Fayos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group studyKirk R Schultz, W Paul Bowman, Alexander Aledo, et al.
Blood|February 4, 2015
Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemiaShannon L Maude, Sibasish Dolai, Cristina Delgado-Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2019
Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology GroupJennifer L McNeer, Meenakshi Devidas, Yunfeng Dai, et al.
JCO Precision Oncology|May 26, 2021
NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical OutcomeXiaonan Zhao, Chelsea Kotch, Elizabeth Fox, et al.
British Journal of Haematology|December 25, 2025
Philadelphia chromosome-positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challengeAdriana Balduzzi, Maria Grazia Valsecchi, Thai Hoa Tran, et al.
Pageof 35